321 related articles for article (PubMed ID: 32248814)
1. Deubiquitinating enzymes (DUBs): DoUBle-edged swords in CNS autoimmunity.
Ruan J; Schlüter D; Wang X
J Neuroinflammation; 2020 Apr; 17(1):102. PubMed ID: 32248814
[TBL] [Abstract][Full Text] [Related]
2. Astrocytes in multiple sclerosis and experimental autoimmune encephalomyelitis: Star-shaped cells illuminating the darkness of CNS autoimmunity.
Yi W; Schlüter D; Wang X
Brain Behav Immun; 2019 Aug; 80():10-24. PubMed ID: 31125711
[TBL] [Abstract][Full Text] [Related]
3. Pattern Recognition Receptors in Multiple Sclerosis and Its Animal Models.
Deerhake ME; Biswas DD; Barclay WE; Shinohara ML
Front Immunol; 2019; 10():2644. PubMed ID: 31781124
[TBL] [Abstract][Full Text] [Related]
4. The contribution of neutrophils to CNS autoimmunity.
Pierson ER; Wagner CA; Goverman JM
Clin Immunol; 2018 Apr; 189():23-28. PubMed ID: 27377536
[TBL] [Abstract][Full Text] [Related]
5. Deubiquitinases as pivotal regulators of T cell functions.
Yang XD; Sun SC
Front Med; 2018 Aug; 12(4):451-462. PubMed ID: 30054854
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptors in multiple sclerosis.
Racke MK; Drew PD
Curr Top Microbiol Immunol; 2009; 336():155-68. PubMed ID: 19688333
[TBL] [Abstract][Full Text] [Related]
7. TRPM2 Exacerbates Central Nervous System Inflammation in Experimental Autoimmune Encephalomyelitis by Increasing Production of CXCL2 Chemokines.
Tsutsui M; Hirase R; Miyamura S; Nagayasu K; Nakagawa T; Mori Y; Shirakawa H; Kaneko S
J Neurosci; 2018 Sep; 38(39):8484-8495. PubMed ID: 30201769
[TBL] [Abstract][Full Text] [Related]
8. Multiple Sclerosis and T Lymphocytes: An Entangled Story.
Legroux L; Arbour N
J Neuroimmune Pharmacol; 2015 Dec; 10(4):528-46. PubMed ID: 25946987
[TBL] [Abstract][Full Text] [Related]
9. The iNOS Activity During an Immune Response Controls the CNS Pathology in Experimental Autoimmune Encephalomyelitis.
Sonar SA; Lal G
Front Immunol; 2019; 10():710. PubMed ID: 31019516
[TBL] [Abstract][Full Text] [Related]
10. Deubiquitinating enzymes (DUBs): decipher underlying basis of neurodegenerative diseases.
Liu B; Ruan J; Chen M; Li Z; Manjengwa G; Schlüter D; Song W; Wang X
Mol Psychiatry; 2022 Jan; 27(1):259-268. PubMed ID: 34285347
[TBL] [Abstract][Full Text] [Related]
11. Regulatory interplay between deubiquitinating enzymes and cytokines.
Woo B; Baek KH
Cytokine Growth Factor Rev; 2019 Aug; 48():40-51. PubMed ID: 31208841
[TBL] [Abstract][Full Text] [Related]
12. Alpha-methylacyl-CoA racemase deletion has mutually counteracting effects on T-cell responses, associated with unchanged course of EAE.
Tafferner N; Barthelmes J; Eberle M; Ulshöfer T; Henke M; deBruin N; Mayer CA; Foerch C; Geisslinger G; Parnham MJ; Schiffmann S
Eur J Immunol; 2016 Mar; 46(3):570-81. PubMed ID: 26648339
[TBL] [Abstract][Full Text] [Related]
13. Tissue Transglutaminase contributes to experimental multiple sclerosis pathogenesis and clinical outcome by promoting macrophage migration.
van Strien ME; de Vries HE; Chrobok NL; Bol JGJM; Breve JJP; van der Pol SMP; Kooij G; van Buul JD; Karpuj M; Steinman L; Wilhelmus MM; Sestito C; Drukarch B; Van Dam AM
Brain Behav Immun; 2015 Nov; 50():141-154. PubMed ID: 26133787
[TBL] [Abstract][Full Text] [Related]
14. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research.
Gold R; Linington C; Lassmann H
Brain; 2006 Aug; 129(Pt 8):1953-71. PubMed ID: 16632554
[TBL] [Abstract][Full Text] [Related]
15. The potential roles of deubiquitinating enzymes in brain diseases.
Lim KH; Joo JY; Baek KH
Ageing Res Rev; 2020 Aug; 61():101088. PubMed ID: 32470641
[TBL] [Abstract][Full Text] [Related]
16. Absence of PI3Kgamma leads to increased leukocyte apoptosis and diminished severity of experimental autoimmune encephalomyelitis.
Rodrigues DH; Vilela MC; Barcelos LS; Pinho V; Teixeira MM; Teixeira AL
J Neuroimmunol; 2010 May; 222(1-2):90-4. PubMed ID: 20303183
[TBL] [Abstract][Full Text] [Related]
17. The double-edged sword of autoimmunity: lessons from multiple sclerosis.
Hestvik AL
Toxins (Basel); 2010 Apr; 2(4):856-77. PubMed ID: 22069614
[TBL] [Abstract][Full Text] [Related]
18. Implications of dietary salt intake for multiple sclerosis pathogenesis.
Hucke S; Wiendl H; Klotz L
Mult Scler; 2016 Feb; 22(2):133-9. PubMed ID: 26447064
[TBL] [Abstract][Full Text] [Related]
19. Deubiquitinating enzymes: potential regulators of the tumor microenvironment and implications for immune evasion.
Hsu SK; Chou CK; Lin IL; Chang WT; Kuo IY; Chiu CC
Cell Commun Signal; 2024 May; 22(1):259. PubMed ID: 38715050
[TBL] [Abstract][Full Text] [Related]
20. Gut Microbiota in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis: Current Applications and Future Perspectives.
Chu F; Shi M; Lang Y; Shen D; Jin T; Zhu J; Cui L
Mediators Inflamm; 2018; 2018():8168717. PubMed ID: 29805314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
